January 17, 2023
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – January 17, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
January 10, 2023
BURLINGTON, Ontario – January 10, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated December 20, 2022, the Company and its auditors are continuing to...
December 29, 2022
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – December 29, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
December 21, 2022
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – December 20, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
December 12, 2022
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – December 12, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
November 7, 2022
BURLINGTON, Ontario – November 7, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...
October 24, 2022
BURLINGTON, Ontario – October 24, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...
October 12, 2022
BURLINGTON, Ontario – October 11, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...
September 28, 2022
BURLINGTON, Ontario – September 29, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of five Canadian companies accepted into this year’s Venture Mentoring Services program offered by the Maryland Tech...
September 23, 2022
BURLINGTON, Ontario – September 23, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery platform today announced that they have entered into a supplier and purchase agreement...